KRAS, NRAS,BRAF mutation testing Doctors Abroad — Page 2

Dr. Mustafa Serkan Alemdar is a clinical oncologist at Medical Park Antalya Hospital Complex. He specializes in treating complex solid tumors and blood cancers. Dr. Alemdar completed his medical degree and oncology fellowship at Akdeniz University. He is an active member of the Turkish Society of Medical Oncology.

• Treats a wide range of cancers including breast, lung, and prostate.
• Expert in hematology-oncology for conditions like leukemia, myeloma, and lymphoma.
• Performs systemic therapies such as chemotherapy, immunotherapy, and targeted biological therapy.
• Works at a facility that houses specialized oncology-bone marrow units and LINAC technology.

Dr. Auala Hubert chairs the Gastrointestinal Cancer Center at Hadassah Medical Center. He uses KRAS, NRAS, and BRAF mutation testing to guide advanced cancer therapies.

• Holds specialist certifications in both medical oncology and radiotherapy
• Performs HIPEC – delivers heated chemotherapy directly into the abdominal cavity
• Member of the Israel Society of Clinical Oncology committee for gastrointestinal cancer
• Uses CyberKnife and Brachytherapy for precise tumor targeting
• Qualified in USMLE standards for medical practice

Dr. Muhammed Mustafa Atci is an Associate Professor of Medical Oncology at Liv Hospital Topkapı. He specializes in treating colon, breast, gastric, and lung cancers. He previously served as the Education Coordinator at Prof. Dr. Cemil Taşcıoğlu City Hospital. Dr. Atci is a member of the American Society of Clinical Oncology (ASCO).

• Author of 19 peer-reviewed papers on gastrointestinal, thoracic, and endocrine cancers.
• Published studies on survival outcomes for stage IIB colon cancer in the Journal of Chemotherapy.
• Researches prognostic biomarkers using PET/CT scans and metabolic tumor volume.
• Treats complex oncological cases at the university-affiliated İstinye University clinic.

Dr. Irfan Cicin is a Professor of Medical Oncology at İstinye University Liv Hospital Topkapı. He specializes in treating complex cancers, including glioblastoma, lung cancer, and pancreatic tumors. He serves as a professor at the Trakya University Faculty of Medicine. Dr. Cicin previously served as a physician in the Turkish Air Force.

• Performs systemic therapies such as immunotherapy, chemotherapy, and hormone therapy.
• Treats a wide range of conditions including gynecologic, orthopedic, and neuro-oncology cases.
• Expert in HIPEC and chemoembolization for liver and abdominal malignancies.
• Works at a 300-bed university hospital with 33 medical departments.

Prof. Beni Boursi is a gastrointestinal oncology specialist at Sheba Medical Center. He uses KRAS, NRAS, and BRAF mutation testing for targeted therapy planning.

• Trained in oncology at the University of Pennsylvania and MD Anderson Cancer Center
• Academic scholar at the Perelman School of Medicine in the United States
• Published research on drug responses in patients with BRAF V600 mutations
• Member of the Israeli Association of Clinical Oncology and Radiotherapy
• Researches microbiome interactions to improve how patients respond to cancer treatments

Dr. Jair Bar is a thoracic oncologist and Deputy Director of the Cancer Center at Sheba Medical Center. He specializes in treating advanced non-small cell lung cancer using personalized immunotherapy and targeted treatments. Dr. Bar holds a PhD in Molecular Biology and leads a research lab focused on immunotherapy resistance.

• Chair of the Israel Lung Cancer Group.
• Board-certified in both Medical Oncology and Radiotherapy Oncology.
• Treats patients at Sheba Medical Center, a top-10 globally ranked hospital.
• Uses molecular and genetic profiling to create precise cancer treatment plans.

Dr. Yaacov Lawrence is the Chair of Radiation Oncology at Sheba Medical Center. He specializes in precision radiation therapy and neuro-oncology. Dr. Lawrence pioneered celiac plexus radiosurgery for pancreatic cancer pain management. He holds the FASTRO designation, one of the highest honors in his specialty.

• Leads the Gastrointestinal Cancer Program at Sheba Medical Center.
• Performs stereotactic radiosurgery for brain tumors and nervous system cancers.
• Authored over 280 scientific publications on personalized radiation protocols.
• Completed radiation oncology fellowship training at Thomas Jefferson University.

Dr. Elnur Sahibov is a specialist in radiation oncology at Emsey Hospital. He provides expertise in oncology services including KRAS, NRAS, and BRAF mutation testing.

• Trained at Marmara University Faculty of Medicine in radiation oncology
• Completed medical specialization between 2012 and 2016
• Graduated from the English-language medical program at Marmara University
• Practices at Emsey Hospital, a private multi-specialty center in Turkey

Professor Eckhart Weidmann heads the hematology department at Nordwest Clinic. KRAS, NRAS, and BRAF mutation testing helps him determine precise therapy for blood disorders.

• Specializes in treating complex blood cancers and non-Hodgkin lymphoma
• Leads a dedicated department at a major German academic hospital
• Focuses on targeted therapies based on genetic mutation profiles
• Member of the German Society of Hematology and Medical Oncology (DGHO)

Dr. Chaitainya Borde has handled more than 30,000 PET scans at HCG Manavata Cancer Centre. This experience supports precise KRAS, NRAS, and BRAF mutation testing for cancer patients.

• Specializes in nuclear medicine – provides detailed imaging for accurate diagnosis
• Expert in all PET-CT scans for tracking cancer growth
• Published medical papers on advanced imaging and therapy
• Experienced in radioiodine and Lu-177 RN therapies for cancer
• Treated 1,000+ thyroid cancer patients using specialized nuclear services

Dr. Raj Nagarkar has performed 50,000+ cancer surgeries. He leads HCG Manavata Cancer Centre, where KRAS, NRAS, and BRAF mutation testing guides surgical planning.

• Completed surgical oncology residency at Tata Memorial Hospital in Mumbai
• Member of the Royal College of Surgeons of Edinburgh
• Participated in over 200 Phase 1–3 clinical trials
• Professor for DNB Superspecialty Surgical Oncology – training future cancer surgeons
• Treats complex cases of liver, pancreatic, and colorectal cancers

Dr. Shaunak Valame is a medical oncologist at HCG Manavata Cancer Centre. He specializes in molecular oncology to guide KRAS, NRAS, and BRAF mutation testing for targeted therapy.

• Earned a DNB in Medical Oncology from the prestigious Indraprastha Apollo Hospital
• Presented stomach cancer research at the ASCO Gastrointestinal Cancer Symposium in San Francisco
• Member of the American Society of Clinical Oncology (ASCO)
• Former lecturer for the International Winter School of Oncology at AIIMS Bhopal
• Provides precision treatment for lung, breast, and gastrointestinal cancers

Dr. Lalit Banswal has performed 10,000 major surgeries. He uses KRAS, NRAS, and BRAF mutation testing to guide surgical treatment for gastrointestinal cancers.

• Fellowship-trained in surgical oncology at Tata Medical Centre in Kolkata
• Serves as Assistant Professor at the State Cancer Institute
• Specializes in robotic and laparoscopic surgery for colon and rectal cancers
• Experienced lead investigator for clinical research in gastrointestinal oncology
• Member of the surgical oncology team at HCG Manavata Cancer Centre

Dr. Antonio Cubillo Gracián pioneered the first liquid biopsy program in Spain. He uses genetic data to guide KRAS, NRAS, and BRAF mutation testing for targeted therapy.

• Heads the Medical Oncology Service at Hospital Universitario HM Sanchinarro
• Directs postgraduate research at HM CIOCC, a leading Spanish cancer center
• Uses molecular markers like EGFR and ALK to design personalized cancer treatment plans
• Leads clinical trials for new cancer therapies through the Start Madrid program
• Member of the teacher faculty at USP CEU medical school

Professor Kayihan Engin is the Director of Oncological Sciences at Medicana Bursa Hospital. He manages gastrointestinal tumor cases where KRAS, NRAS, and BRAF mutation testing is essential for treatment planning.

• Completed a post-doctoral fellowship at Thomas Jefferson University in the USA
• Former Coordinator of Oncological Sciences at the Anadolu Medical Center
• Expert in gastrointestinal tumors including colorectal, esophageal, and liver cancers
• Conducted advanced research at the National Cancer Institute in Bethesda
• Served as Chairman of Radiation Oncology at Uludağ University Medical College

Dr. Shruti Kate heads the oncology department at HCG Manavata Cancer Centre. She previously served as a consultant at the prestigious Tata Memorial Hospital.

• Specializes in solid tumors and pediatric cancers requiring KRAS, NRAS, and BRAF mutation testing
• Presented lung cancer research at the 2018 World Conference on Lung Cancer in Toronto
• Won a travel award from the International Association for the Study of Lung Cancer
• Member of the American Society of Clinical Oncology and the European Society for Medical Oncology
• Expert in using immunotherapy and metronomic therapy for advanced cancer stages